![]() |
Montelukast sodium
- 英文名称:Montelukast sodium
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10737
- cas:151767-02-1
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B10737 |
用途 | 科研检测 |
英文名称 | Montelukast sodium |
包装规格 | 1MG |
CAS编号 | 151767-02-1 |
别名 | Montelukast sodium |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by HPLC,;NMR (Conforms)
分子式:C35H35ClNO3S Na
分子量:608.17
溶剂:DMSO (60 mg/ml) Water (30 mg/ml) Ethanol (60 mg/ml)
性状:Solid
存储:-20°C
Activity (short version):Leukotriene CysLT1 antagonist and GPR17 antagonist
Function / Pharmacology:Potent, selective CysLT1 receptor (leukotriene D4) antagonist (Ki = 0.18 nM).1,2 Displays anti-inflammatory and anti-asthmatic effects. Clinically useful agent for treatment of chronic asthma.3 Attenuates chronic brain injury after focal cerebral ischemia in rodent models.4 Decreases blood brain barrier dysfunction in mouse models.5 Blockade of GPR17 by montelukast elevates neural stem and progenitor proliferation.6
分子式:C35H35ClNO3S Na
分子量:608.17
溶剂:DMSO (60 mg/ml) Water (30 mg/ml) Ethanol (60 mg/ml)
性状:Solid
存储:-20°C
Activity (short version):Leukotriene CysLT1 antagonist and GPR17 antagonist
Function / Pharmacology:Potent, selective CysLT1 receptor (leukotriene D4) antagonist (Ki = 0.18 nM).1,2 Displays anti-inflammatory and anti-asthmatic effects. Clinically useful agent for treatment of chronic asthma.3 Attenuates chronic brain injury after focal cerebral ischemia in rodent models.4 Decreases blood brain barrier dysfunction in mouse models.5 Blockade of GPR17 by montelukast elevates neural stem and progenitor proliferation.6